Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
Ultra-high purity surfactant for biologics and parenteral drug formulations
The facility has been classified as Voluntary Action Indicated
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Zydus will work closely with the USFDA to address and resolve the observations in an expeditious manner
It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks
Subscribe To Our Newsletter & Stay Updated
